Drug Use and Abuse

  • David Rees Jones


In 1917 Sollmann wrote, “Pharmacology ... comprises ... a large mass of minute details, which would constitute too great a tax on human memory, but which cannot safely be neglected.” If that were true in 1917, before synthetic drugs had begun to replace the older natural medicines, then how much more relevant it is today when the modern physician can choose to prescribe from any of 36,000 chemical preparations. A detailed knowledge of so large a number of drugs is clearly impossible, and to be safe the physician must be selective; he must prescribe from a small number of preparations which he knows well. In short, he must have a personal pharmacopeia.


Psychotropic Drug Antibiotic Prescribe Erythema Multiforme Heroin Addict Causal Microorganism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bain DJG, Haines AJ: A year’s study of drug prescribing in general practice using computor assisted records. J R Coll Gen Pract 25:41, 1975PubMedGoogle Scholar
  2. 2.
    Balint M, Hunt J, Joyce D, Marinker ML, Woodcock J: Treatment or Diagnosis. London, Tavistock, 1970Google Scholar
  3. 3.
    Balter MB, Levine J, Manheimer DI: Cross national study of the extent of anti-anxiety sedative drug use. N Engl J Med 290:769, 1974PubMedCrossRefGoogle Scholar
  4. 4.
    Barlow AJE, Chattaway FW: Observations on the carriage of Candida albicans in man. Br J Dermatol 81:103, 1969PubMedCrossRefGoogle Scholar
  5. 5.
    Barr DP: Hazards of modern diagnosis and therapy. The price we pay. JAMA 159:1452, 1955CrossRefGoogle Scholar
  6. 6.
    Barr WH, Gerbracht LM, Letcher K, Plaut M, Strahl N: Assessment of the biologic availability of tetracycline products in man. Clin Pharmacol Ther 13:97, 1972PubMedGoogle Scholar
  7. 7.
    Blair, DC, Barnes RW, Wildner EL, Murray WJ: Biological availability of Oxytetracycline HCl capsules. JAMA 215:251, 1971CrossRefGoogle Scholar
  8. 8.
    Bodenham KE, Wellman F: Foundations for Health Service Management. London, Oxford Univ Press, 1972Google Scholar
  9. 9.
    Brown P, Baddeley H, Read AE, Davies JD, McGarry J: Sclerosing peritonitis, an unusual reaction to a beta-adregenic blocking drug (Practolol). Lancet 2:1477, 1974PubMedCrossRefGoogle Scholar
  10. 10.
    Clarke CA, Evans DAP, Harris R, Woodrow JC: Genetics in medicine. A review. II. Pharmacogenetics Q J 37:183, 1968Google Scholar
  11. 11.
    Collier PS: Prescribing of oral contraceptives. Lancet 1:1132, 1973PubMedCrossRefGoogle Scholar
  12. 12.
    Department of Health and Social Security: Health and Personal Social Services Statistics. London, HMSO, 1975Google Scholar
  13. 13.
    Dunlop D: Drug control and the British Health Service. Ann Intern Med 71:237, 1969PubMedCrossRefGoogle Scholar
  14. 14.
    Dunlop D: Abuse of drugs by the public and by doctors. Br Med Bull 26:236, 1970PubMedGoogle Scholar
  15. 15.
    Dunnell K, Cartwright A: Medicine Takers, Hoarders, and Prescribers. London, Routledge and Kegan Paul, 1972Google Scholar
  16. 16.
    Glazko AJ, Kinkel AW, Algnani WC, and Holmes EL: An evaluation of the absorption characteristics of different chloramephenicol preparations in normal human subjects. Clin Pharmacol Ther 9:472, 1968PubMedGoogle Scholar
  17. 17.
    Hood HE, Wade OL: Uses of amphetamines in general practice. Lancet 2:96, 1968CrossRefGoogle Scholar
  18. 18.
    Howie JGR: A new look at respiratory illness in general. A reclassification of respiratory illness based on antibiotic prescribing. J R Coll Gen Pract 23:895, 1973PubMedGoogle Scholar
  19. 19.
    Howie JGR: The case against use of antibiotics in upper respiratory tract illness. Update 10:1351, 1975Google Scholar
  20. 20.
    Howie JGR, Clark GA: Double blind trial of early demethylchlortetracycline in minor respiratory illness in general practice. Lancet 2:1099, 1970PubMedCrossRefGoogle Scholar
  21. 21.
    Howie JGR, Richardson IM, Gill G, Durno D: Respiratory illness and antibiotic use in general practice. J R Coll Gen Pract 21:657, 1971PubMedGoogle Scholar
  22. 22.
    Howie JH: Symposium on Antibiotics in General Practice. Queensborough, Kent, England, Abbott Laboratories, 1977Google Scholar
  23. 23.
    Jones DIR: Self poisoning with drugs, the past 20 years in Sheffield. Br Med J 1:28, 1977PubMedCrossRefGoogle Scholar
  24. 24.
    Kessel N: Self poisoning. Br Med J 2:1265, 1965PubMedCrossRefGoogle Scholar
  25. 25.
    Leading Article: The bioavailability of digoxin. Lancet 2:311, 1972Google Scholar
  26. 26.
    Lee JAH, Draper P, Weatherall M: Prescribing in three English towns. Millbank Mem Fund Q Bull 43: 285, 1965CrossRefGoogle Scholar
  27. 27.
    MacDonald MG, MacKay BR: Adverse drug reactions. JAMA 190:115, 1964CrossRefGoogle Scholar
  28. 28.
    Madden TA: Adverse pencillin reactions in the records of a general practice. J R Coll Gen Pract 27:73, 1977PubMedGoogle Scholar
  29. 29.
    Ministry of Health: Recent National Health Service Prescribing Trends. Reports on Public Health and Medical Subjects, Number 110. London, HMSO, 1964Google Scholar
  30. 30.
    Mulroy R: Iatrogenic disease in general practice. Its incidence and effects. Br Med J 2:407, 1973PubMedCrossRefGoogle Scholar
  31. 31.
    Oates JA, Mitchell JR, Feagin OT, Kaufmann JS, Shand DG: Distribution of guanidium antihypertensives. Mechanism of their selective action. Ann NY Acad Sci 179:302, 1971PubMedCrossRefGoogle Scholar
  32. 32.
    Parish PA, Williams WM, Elmes PC: The medical use of psychotropic drugs. J R Coll Gen Pract 23 (Suppl 2):1, 1973Google Scholar
  33. 33.
    Parry HS, Balter MB, Mellinger GD, Cisin IH, Mannheimer DI: National patterns of psychotherapeutic drug use. Arch Gen Psychiatry 28:769, 1973CrossRefGoogle Scholar
  34. 34.
    Petrie JC, Howie JGR, Durno D: Awareness and experience of general practitioners of selected drug interactions. Br Med J 2:262, 1974PubMedCrossRefGoogle Scholar
  35. 35.
    Ross PW: Accuracy of clinical assessment of the microbial etiology of sore throat. Practitioner 207:659, 1971PubMedGoogle Scholar
  36. 36.
    Schimmel EM: The physician as pathogen. J Chronic Dis 16:1, 1963PubMedCrossRefGoogle Scholar
  37. 37.
    Searl RO, Pernarowski M: The biopharmaceutical properties of solid dosage forms. Can Med Assoc J 96:1513, 1967PubMedGoogle Scholar
  38. 38.
    Shaw TRD, Howard MR, Hamer J: Variation in the biological availability of digoxin. Lancet 2:303, 1972PubMedCrossRefGoogle Scholar
  39. 39.
    Stolley PD, Lasagna L: Prescribing patterns of physicians. J Chronic Dis 22:395, 1969PubMedCrossRefGoogle Scholar
  40. 40.
    Stolley PD, McEvilla JD, Sloane LM: Drug prescribing and use in an American community. Ann Intern Med 76:537, 1972PubMedCrossRefGoogle Scholar
  41. 41.
    Thomsen PE, Ostenfeld HOL, Kristensen N: Klor-propamid. Fenylbutazon som arsag til hypoglykaemi. Ugesker Laeger 132:1722, 1970Google Scholar
  42. 42.
    Trethowan WH: Pills for personal problems. Br Med J 3:749, 1975PubMedCrossRefGoogle Scholar
  43. 43.
    Varley AB: The generic inequivalence of drugs. JAMA 206:1745, 1968PubMedCrossRefGoogle Scholar
  44. 44.
    Wade OL: The use of publications about drugs to general practitioners. J R Coll Gen Pract 12:277, 1966Google Scholar
  45. 45.
    Wagner JG, Welling PG, Lee UP, Walker JE: In vivo and in vitro availability of commercial warfarin tablets. J Pharmacol Sci 60:666, 1971CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1978

Authors and Affiliations

  • David Rees Jones

There are no affiliations available

Personalised recommendations